You are here: Industry Insights > emerging markets

News List

High-value molecules going off-patent – from an emerging markets perspective Dr. Preet Pal S.B.
August 31, 2021
These are high perspective 10 small molecules that mid-cap manufacturers in emerging markets can consider adding to their product portfolio.
Glenmark Pharma secures its position in Dow Jones Sustainability Emerging Markets Index expresspharma
November 27, 2020
Over 800 companies across sectors from the emerging markets were assessed, out of which 100 made it to the prestigious index this year including 11 from India.
ConvaTec sharpens focus on Asia Pacific and emerging markets prnasia
March 02, 2020
ConvaTec Group Plc is putting the Asia Pacific region, along with Latin America, The Middle East and Africa, at the forefront of its new operating model by establishing a fully integrated business unit called the Global Emerging Markets (GEM), according t
Takeda mulling sale of emerging market drugs – report pharmaphorum
January 23, 2019
Takeda could be considering selling some emerging-market drugs in a bid to cut debts following its merger with Shire that completed earlier this month, according to a press report.
GSK wraps up promised Horlicks sell-off in £3.1B deal with Unilever fiercepharma
December 04, 2018
After weighing options and offers for its Horlicks drinks brand in India for several months, GlaxoSmithKline signed off on a £3.1 billion sale to Unilever. The cash will help GSK cover the cost of its
AstraZeneca H1 results: new drugs and emerging markets fuel growth pharmaceutical-technology
July 30, 2018
AstraZeneca has announced new medicines and emerging markets have driven its growth in the first half (H1) of 2018. This has been partially offset by the loss of Crestor exclusivity in Europe and Japan.
Peripheral Vascular Procedure Volumes: Global Analysis, Rapid Growth in Emerging Markets en-cphi.cn
May 18, 2017
Medtech and pharmaceutical companies continue to plan and strategize carefully around the large peripheral vascular procedure caseloads in the major US and European markets...
ICCO Netherlands invests in VIVO Healthcare biospectrumasia
March 22, 2017
VIVO plans to expand into various emerging markets with the purpose of training large number of healthcare workers
Emerging markets better bet than developed markets.Biolife solutions etc., top companies in the glob pharmaasia
March 07, 2017
Biolife solutions, lifeline scientific, Sigma-Aldrich, Biocision and Cesca Therapeutics top companies in the global biopreservation market.